Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Palmitic acid
Price: Check
Purity: 98.0%
Stocking Period: 10 Day
Contact: Yang
Email: sales@echemcloud.com

2911655-93-9

2911655-93-9 structure

2911655-93-9 structure

Name: FAK-IN-9
Chemical Name: FAK-IN-9
CAS Number: 2911655-93-9
Molecular Formula: C₃₆H₃₈ClN₇O₈S
Molecular Weight: 764.25
Catalog: Signaling Pathways Protein Tyrosine Kinase/RTK FAK
Create Date: 2023-06-01 13:54:10
Modify Date: 2024-04-09 13:54:29
FAK-IN-9 (Compound 8f) is a potent and orally active FAK inhibitor with an IC50 of 27.44 nM. FAK-IN-9 induces triple-negative breast cancer (TNBC) cell apoptosis[1].

Name	FAK-IN-9

Description	FAK-IN-9 (Compound 8f) is a potent and orally active FAK inhibitor with an IC50 of 27.44 nM. FAK-IN-9 induces triple-negative breast cancer (TNBC) cell apoptosis[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Protein Tyrosine Kinase/RTK >> FAK
Target	IC50: 27.44 nM (FAK)[1]
In Vitro	FAK-IN-9 (Compound 8f; 72 h) 抑制 MDA-MB-157、MDA-MB-231 和 MDA-MB-453 细胞增殖，IC50 分别为 0.167±0.025、0.126±0.012 和 0.159±0.017 μM [1]。 FAK-IN-9 (1-4 μM; 72 h) 导致 MDA-MB-231 细胞以剂量依赖的方式产生相对较高水平的 NO[1]。 FAK-IN-9 (1-4 μM; 48 h) 抑制 MDA-MB-231 细胞的侵袭和迁移[1]。 FAK-IN-9 (1-4 μM; 72 h) 有效阻断 FAK 介导的信号通路[1]。 FAK-IN-9 (4 μM; 72 h) 抑制 MDA-MB-231 细胞局灶粘连 (FAs) 和应力纤维 (SFs) 的形成[1]。 FAK-IN-9 (1-4 μM; 72 h) 诱导 MDA-MB-231 细胞凋亡[1]。 Cell Proliferation Assay[1] Cell Line: MDA-MB-157, MDA-MB-231, MDA-MB-453 and MCF10A Concentration: Incubation Time: 72 h Result: Inhibited proliferation with IC50s of 0.167±0.025, 0.126±0.012, 0.159±0.017 and 2.401±0.131 μM against MDA-MB-157, MDA-MB-231, MDA-MB-453 and MCF10A, respectively. Cell Invasion Assay[1] Cell Line: MDA-MB-231 cells Concentration: 1, 2 and 4 μM Incubation Time: 48 h Result: The numbers of invasive MDA-MB-231 cells were reduced dose-dependently. Cell Migration Assay [1] Cell Line: MDA-MB-231 cells Concentration: 1, 2 and 4 μM Incubation Time: 48 h Result: Remarkably block the migration of MDA-MB-231 cells in a dose-dependent manner. Western Blot Analysis[1] Cell Line: MDA-MB-231 cells Concentration: 1, 2 and 4 μM Incubation Time: 72 h Result: Potently suppressed the autophosphorylation of Y397 in a dose-dependent manner. Decreased the levels of p-AKT, MMP-2 and MMP-9 dose dependently. Apoptosis Analysis[1] Cell Line: MDA-MB-231 cells Concentration: 1, 2 and 4 μM Incubation Time: 72 h Result: The percentage of apoptotic MDA-MB-231 cells gradually increased ranging from 19.06% to 77.66% at 4 μM.
In Vivo	FAK-IN-9 (Compound 8f; 15 or 30 mg/kg; oral; once daily for 30 days) 抑制小鼠 MDA-MB-231 肺转移[1]。 Animal Model: BALB/c nude mice, MDA-MB-231 experimental pulmonary metastasis model[1] Dosage: 15 or 30 mg/kg Administration: Oral, once daily for 30 days Result: Potently reduced the numbers of lung tumor nodules dose-dependently.
References	[1]. Zhang J, et al. Design, synthesis and evaluation of nitric oxide releasing derivatives of 2,4-diaminopyrimidine as novel FAK inhibitors for intervention of metastatic triple-negative breast cancer. Eur J Med Chem. 2023 Mar 15;250:115192.

Molecular Formula	C₃₆H₃₈ClN₇O₈S
Molecular Weight	764.25

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.